ResearcherNational Taiwan UniversityNo recent work listed
Tzu‐Pin Lu
Matched on ORCID iD 0000-0003-3697-0386; OpenAlex author ID A5025739002. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: 2 papers
Papers 3
- Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry. Co-author DOI 10.1245/s10434-021-11030-w↗
- ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients. Last author DOI 10.1245/s10434-021-11041-7↗
- Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy. Co-author DOI 10.1007/s00330-020-07294-7↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yu‐Wen Tien · 3 shared papers, 2021–2022 · strength 0.54
- Paper ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients. DOI 10.1245/s10434-021-11041-7↗
- Paper Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduo… DOI 10.1007/s00330-020-07294-7↗
- Paper Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillanc… DOI 10.1245/s10434-021-11030-w↗
- Amrita Sengupta Chattopadhyay · 2 shared papers, 2022 · strength 0.38
- Paper ASO Author Reflections: Identification of Prognostic Factors for Stage-III Pancreatic Ductal Adenocarcinoma patients. DOI 10.1245/s10434-021-11041-7↗
- Paper Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillanc… DOI 10.1245/s10434-021-11030-w↗
- Yan-Chih Peng · 1 shared paper, 2021 · strength 0.16
- Bang‐Bin Chen · 1 shared paper, 2021 · strength 0.16
- Wen-Chung Lee · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.